| Occurrence of erectile dysfunction, testosterone deficiency syndrome and metabolic syndrome in patients with abdominal obesity. Where is a sufficient level of testosterone? | |
| | |
MedLine Citation:
|
PMID: 22315154 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
AIM: The aim of this study was to determine the prevalence of erectile dysfunction (ED), testosterone deficiency syndrome (TDS), and metabolic syndrome in patients with abdominal obesity (AO) and the prevalence of morbidity at different levels of testosterone (TST). BACKGROUND: Male sex hormones play an important role in ED and variety of TDS and may have influence on the development of metabolic syndrome. The number of men with AO which constitutes a serious health risk is continuously growing. Currently, there are different views that TST levels are already insufficient, and the patient should benefit from treatment. OBJECTIVES: This study examined the association between ED, testosterone level and metabolic syndrome in men with AO. DESIGN, SETTING, AND PARTICIPANTS: The study was carried out in an outpatient urology center of Urology Clinic and Obesity Center of the Clinic of Internal Medicine. There were 167 participants-men with AO which were examined as part of preventive examination. METHODS: Hormonal, a complete urological and internal evaluation was carried out in every patient. RESULTS AND LIMITATIONS: We found some degree of ED in 73% (122/167) in men with AO. The TST levels below 14 nmol/l had of these 122 patients 84 patients (68.9%) and 49 patients (40.2%) below 10 nmol/l. In this group of patients, we found 103/167 patients (61.7%) with metabolic syndrome. When we compared TST level and morbidity, we found significantly more patients with diabetes mellitus (DM), hypertension and dyslipidemia in group with TST below 10 nmol/l. We also found difference in the levels of HDL cholesterol and triglycerides in the group of patients with TST 10-14 and over 14 nmol/l. CONCLUSION: Patients over 40 years of age with AO and ED should also be examined for TDS and metabolic syndrome. In this group of patients we found that 113/167 patients (67.6%) had total TST below 14 nmol/l, and sufficient level of TST seems to be above this level. |
| | |
Authors:
|
Juraj Fillo; Jan Breza; Michaela Levčíkova; Jan Luha; Anna Vachulova; Stefan Durdík; Peter Labaš |
Related Documents
:
|
22449504 - Multidisciplinary treatment approach in treacher collins syndrome. 22396144 - Mini-review: pheochromocytomas causing the ectopic acth syndrome. 1941794 - Testicular regression syndrome. a case report. 22570644 - Severe developmental delay in a patient with 7p21.1-p14.3 microdeletion spanning the tw... 3030594 - Vascular disorders. 21232734 - Idiopathic corporeal hemihypertrophy associated with hemihypertrichosis. |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-2-8 |
Journal Detail:
|
Title: International urology and nephrology Volume: - ISSN: 1573-2584 ISO Abbreviation: - Publication Date: 2012 Feb |
Date Detail:
|
Created Date: 2012-2-8 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0262521 Medline TA: Int Urol Nephrol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Urology, Comenius University, Bratislava, Slovakia, juraj.fillo@gmail.com. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: In situ randomised trial to investigate the occluding properties of two desensitising toothpastes on...
Next Document: Goserelin versus leuprolide in the chemical castration of patients with prostate cancer.